Ricky Goldwasser
Stock Analyst at Morgan Stanley
(3.43)
# 909
Out of 4,944 analysts
239
Total ratings
65%
Success rate
9.59%
Average return
Main Sectors:
Stocks Rated by Ricky Goldwasser
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CNC Centene | Maintains: Equal-Weight | $33 → $28 | $27.00 | +3.70% | 13 | Aug 4, 2025 | |
| LH Labcorp Holdings | Maintains: Overweight | $283 → $306 | $269.36 | +13.60% | 17 | Jul 25, 2025 | |
| UNH UnitedHealth Group | Maintains: Overweight | $563 → $374 | $270.21 | +38.41% | 17 | May 14, 2025 | |
| DOCS Doximity | Maintains: Equal-Weight | $71 → $60 | $63.31 | -5.23% | 10 | Apr 24, 2025 | |
| CRL Charles River Laboratories International | Maintains: Equal-Weight | $220 → $184 | $154.14 | +19.37% | 22 | Feb 5, 2025 | |
| LFST LifeStance Health Group | Reiterates: Overweight | $10 | $5.25 | +90.48% | 8 | Apr 22, 2024 | |
| GDRX GoodRx Holdings | Maintains: Equal-Weight | $8 → $5.5 | $3.49 | +57.82% | 9 | Nov 10, 2023 | |
| OSCR Oscar Health | Maintains: Equal-Weight | $5 → $7.5 | $14.57 | -48.52% | 6 | Aug 30, 2023 | |
| ALHC Alignment Healthcare | Maintains: Overweight | $19 → $12 | $14.78 | -18.81% | 8 | Aug 30, 2023 | |
| DGX Quest Diagnostics | Reiterates: Equal-Weight | $145 | $177.74 | -18.42% | 17 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $365 | $159.98 | +128.15% | 7 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $403 → $420 | $664.20 | -36.77% | 27 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $140 → $120 | $7.07 | +1,597.31% | 7 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $549 → $620 | $280.12 | +121.33% | 11 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $485 → $500 | $292.65 | +70.85% | 2 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $127 → $124 | $66.35 | +86.89% | 9 | Oct 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $296 → $318 | $287.55 | +10.59% | 11 | Aug 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $74 → $70 | $149.75 | -53.26% | 17 | Jul 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $43 → $39 | $11.93 | +226.91% | 15 | Jul 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $182 → $195 | $187.48 | +4.01% | 6 | Oct 21, 2020 |
Centene
Aug 4, 2025
Maintains: Equal-Weight
Price Target: $33 → $28
Current: $27.00
Upside: +3.70%
Labcorp Holdings
Jul 25, 2025
Maintains: Overweight
Price Target: $283 → $306
Current: $269.36
Upside: +13.60%
UnitedHealth Group
May 14, 2025
Maintains: Overweight
Price Target: $563 → $374
Current: $270.21
Upside: +38.41%
Doximity
Apr 24, 2025
Maintains: Equal-Weight
Price Target: $71 → $60
Current: $63.31
Upside: -5.23%
Charles River Laboratories International
Feb 5, 2025
Maintains: Equal-Weight
Price Target: $220 → $184
Current: $154.14
Upside: +19.37%
LifeStance Health Group
Apr 22, 2024
Reiterates: Overweight
Price Target: $10
Current: $5.25
Upside: +90.48%
GoodRx Holdings
Nov 10, 2023
Maintains: Equal-Weight
Price Target: $8 → $5.5
Current: $3.49
Upside: +57.82%
Oscar Health
Aug 30, 2023
Maintains: Equal-Weight
Price Target: $5 → $7.5
Current: $14.57
Upside: -48.52%
Alignment Healthcare
Aug 30, 2023
Maintains: Overweight
Price Target: $19 → $12
Current: $14.78
Upside: -18.81%
Quest Diagnostics
Aug 3, 2023
Reiterates: Equal-Weight
Price Target: $145
Current: $177.74
Upside: -18.42%
Jul 14, 2023
Reiterates: Overweight
Price Target: $365
Current: $159.98
Upside: +128.15%
Jan 6, 2023
Maintains: Overweight
Price Target: $403 → $420
Current: $664.20
Upside: -36.77%
Jan 6, 2023
Maintains: Overweight
Price Target: $140 → $120
Current: $7.07
Upside: +1,597.31%
Oct 31, 2022
Maintains: Overweight
Price Target: $549 → $620
Current: $280.12
Upside: +121.33%
Oct 21, 2022
Maintains: Equal-Weight
Price Target: $485 → $500
Current: $292.65
Upside: +70.85%
Oct 11, 2022
Maintains: Overweight
Price Target: $127 → $124
Current: $66.35
Upside: +86.89%
Aug 17, 2022
Maintains: Overweight
Price Target: $296 → $318
Current: $287.55
Upside: +10.59%
Jul 14, 2022
Maintains: Overweight
Price Target: $74 → $70
Current: $149.75
Upside: -53.26%
Jul 6, 2022
Maintains: Underweight
Price Target: $43 → $39
Current: $11.93
Upside: +226.91%
Oct 21, 2020
Maintains: Overweight
Price Target: $182 → $195
Current: $187.48
Upside: +4.01%